Posttransplantation lymphoproliferative disorder in children: Clinical, histopathologic, and imaging features

Radiology

Volumn 217, Issue 1, 2000, Pages 16-25

  Pickhardt, P J ^a   Siegel, M J ^a   Hayashi, R J ^a   Kelly, M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epstein Barr virus; Heart, transplantation; Kidney, transplantation; Liver, transplantation; Lung, transplantation; Lymphoma, CT; Lymphoma, in infants and children; Lymphoma, MR; State of the Art; Transplantation; Ultrasound (US), in infants and children

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; ANTINEOPLASTIC AGENT; CYTOKINE; GANCICLOVIR; HYPERIMMUNE GLOBULIN; IMMUNOSUPPRESSIVE AGENT;

ABDOMINAL RADIOGRAPHY; ALLOGRAFT; CANCER THERAPY; CHILD; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; ECHOGRAPHY; EPSTEIN BARR VIRUS; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INCIDENCE; LYMPHOID CELL; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; NEURORADIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THORAX RADIOGRAPHY; TRANSPLANTATION; TREATMENT PLANNING;

EID: 0034538704     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.217.1.r00oc3816     Document Type: Review

References (78)

1. Pediatric transplantation
2. Indications for pediatric liver transplantation
3. Fifteen years of pediatric heart transplantation at the University of Pittsburgh: Lessons learned and future prospects
4. Pediatric renal transplantation: A review of the UNOS data
5. Pediatric lung transplantation: Indications, techniques, and early results
6. Pediatric lung transplantation at St Louis Children's Hospital, 1990-1995
7. Pediatric organ transplantation
8. Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD)
9. Posttransplantation lymphoproliferative disorders (PTLD): Current perspectives
10. The pathology of post-transplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression
11. The diagnosis and treatment of posttransplant lymphoproliferative disorders
12. The problem of cancer in organ transplant recipients: An overview
13. De novo malignancies in pediatric organ transplant recipients
14. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children
15. Molecular genetic analysis of post-transplant lymphoproliferative disorders
16. Epstein-Barr viral infection and posttransplantation lymphoproliferative disorders in liver transplantation
17. Clinical characteristics of posttransplant lymphoproliferative disorders
18. Acquired immunodeficiency syndrome-associated lymphomas: Clinical, pathologic, immunologic, and viral characteristics of 111 cases
19. Lymphoproliferative diseases in immunocompromised hosts: The role of Epstein-Barr virus
20. Genetically determined immunodeficiency diseases (GDID) and malignancy: Report from the immunodeficiency-cancer registry
21. Therapy for transplant-related lymphoproliferative diseases
22. Immunosuppression: A contributing factor in lymphoma formation
23. Lymphoproliferative disorders after organ transplantation in children
24. Lymphoproliferative diseases in children
25. Chest radiography as a predictor of outcome in posttransplantation lymphoproliferative disorder in lung allograft recipients
26. Orthotopic liver transplantation, Epstein-Barr virus, cyclosporine, and lymphoproliferative disease: A growing concern
27. Posttransplantation lymphoproliferative disease in pediatric liver transplantation
28. The involvement of the gastrointestinal tract in posttransplantation lymphoproliferative disease in pediatric liver transplantation
29. Posttransplantation lymphoproliferative disorders in pediatric thoracic organ recipients
30. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation
31. Epstein-Barr virus associated posttransplant lymphoproliferative disease after intestinal transplantation
32. Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency
33. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation
34. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor of posttransplant lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations
35. Post-transplant lymphoproliferative disorder in renal allograft recipients: Clinical experience and risk factor analysis in a single center
36. Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: The role of cytomegalovirus disease
37. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients
38. Abdominal manifestations of posttransplantation lymphoproliferative disorder
39. Posttransplantation lymphoproliferative disorder of the abdomen: CT evaluation in 51 patients
40. Involvement of the gastrointestinal tract by Epstein-Barr virus-associated posttransplant lymphoproliferative disorders
41. Inclusion of infectious mononucleosis in the spectrum of Epstein-Barr virus infections in transplant recipients
42. Changes in tonsils and adenoids in children with posttransplant lymphoproliferative disorder: Report of three cases with early involvement of Waldeyer's ring
43. Neuroimaging in posttransplant lymphoproliferative disorder
44. Posttransplant lymphoproliferative disorder presenting as an isolated skin lesion
45. Posttransplant lymphoproliferative disorders: A fine-needle aspiration biopsy study
46. Role of the fine-needle aspiration in the clinical management of transplant patients
47. Cytologic features of post-transplant lymphoproliferative disorder
48. Risk of cancer in renal transplant recipients
49. Malignant lymphomas in transplantation patients
50. Posttransplant lymphoproliferative disorders (PTLD): Summary of Society for Hematopathology workshop
51. Epstein-Barr virus-induced T cell lymphoma in solid organ transplant recipients
52. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients
53. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders
54. Lymphoproliferative disorders after organ transplantation: A report of 24 cases observed in a single institution
55. The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant
56. Clonal analysis of posttransplant lymphoproliferative disorders, using both episomal Epstein-Barr virus and immunoglobulin genes as markers
57. Molecular genetic analysis of lymphoid tumors arising after organ transplantation
58. Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients affected with the human immunodeficiency virus
59. Rational management of posttransplant lymphoproliferative disorder in pediatric recipients
60. Aggressive treatment for postcardiac transplant lymphoproliferation
61. Treatment of Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: Two cases after solid organ transplantation
62. Successful treatment of severe Epstein-Barr virus infection with ganciclovir and cytomegalovirus hyperimmune globulin following kidney transplantation
63. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation
64. Treatment of B cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin
65. Clinical protocol administration of neomycin resistant gene marked EBV specific cytotoxic T lymphocytes to recipients of mismatched or phenotypically similar unrelated donor marrow grafts
66. Anti-B cell antibodies for the treatment of monoclonal Epstein-Barr virus-induced lymphoproliferative syndrome after multivisceral transplantation
67. Non-Hodgkin lymphoma after liver transplantation: Response to chemotherapy
68. Monoclonality of lymphoproliferative lesions in cardiactransplant recipients
69. Lymphoproliferative disorders and hematologic malignancies following organ transplantation
70. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-prednisone therapy
71. Lymphoproliferative disorders: CT findings in immunocompromised children
72. Hepatic lymphoma in cyclosporine-treated transplant recipients: Sonographic and CT findings
73. Lymphoproliferative disease after liver transplantation: Primary biliary localization
74. Complex posttransplantation abnormalities of renal allograffs: Evaluation with MR imaging
75. Analysis of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after lung transplantation
76. Lymphoproliferative disorders after lung transplantation: Imaging features
77. Posttransplant lymphoproliferative disorder: Intrathoracic manifestations
78. Invasive pulmonary aspergillosis in acute leukemia: Characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis